Prevalence and risk factors for postoperative incisional hernia after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta‑analysis and systematic review
Videosurgery and Other Miniinvasive Techniques · 24.06.2026 · 111-120
DOI: 10.20452/wiitm.2026.18032 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Videosurgery and Other Miniinvasive Techniques, erschienen am 24.06.2026. Verfasst von Qing Zeng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department Ganzhou People's Hospital China. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Department Ganzhou People's Hospital China.
- Department of Obstetrics, Ganzhou Maternal and Child Health Hospital, Ganzhou, Jiangxi Province, China.
- Department of Gynecology, Ganzhou Maternal and Child Health Hospital, China.
Zitieren
APA
Zeng, Q., Yuan, X., & Wei, X. (2026). Prevalence and risk factors for postoperative incisional hernia after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta‑analysis and systematic review. Videosurgery and Other Miniinvasive Techniques, 111-120. https://doi.org/10.20452/wiitm.2026.18032
Vancouver
Zeng Q, Yuan X, Wei X. Prevalence and risk factors for postoperative incisional hernia after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta‑analysis and systematic review. Videosurgery and Other Miniinvasive Techniques. 2026:111-120. doi:10.20452/wiitm.2026.18032
BibTeX
@article{Zeng2026,
author = {Zeng, Qing and Yuan, Xianping and Wei, Xing},
title = {Prevalence and risk factors for postoperative incisional hernia after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta‑analysis and systematic review},
journal = {Videosurgery and Other Miniinvasive Techniques},
year = {2026},
pages = {111--120},
doi = {10.20452/wiitm.2026.18032}
}
EUVIMED